These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38414528)

  • 1. Impact of the diseased lung microenvironment on the in vivo fate of inhaled particles.
    Gai J; Liu L; Zhang X; Guan J; Mao S
    Drug Discov Today; 2024 Jul; 29(7):104019. PubMed ID: 38729235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Molecular Therapeutics for Pulmonary Diseases: Addressing the Need for Precise Drug Delivery.
    Carneiro S; Müller JT; Merkel OM
    Handb Exp Pharmacol; 2024; 284():313-328. PubMed ID: 38177399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives.
    Costabile G; Conte G; Brusco S; Savadi P; Miro A; Quaglia F; d'Angelo I; Ungaro F
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects.
    Zheng M; Zhu W; Gao F; Zhuo Y; Zheng M; Wu G; Feng C
    J Nanobiotechnology; 2024 Mar; 22(1):136. PubMed ID: 38553716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.
    Youngren-Ortiz SR; Gandhi NS; España-Serrano L; Chougule MB
    Kona; 2016 Feb; 33():63-85. PubMed ID: 27081214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary delivery of nano-particles for lung cancer diagnosis and therapy: Recent advances and future prospects.
    A R; Han Z; Wang T; Zhu M; Zhou M; Sun X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1933. PubMed ID: 37857568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
    Xie L; Xie D; Du Z; Xue S; Wang K; Yu X; Liu X; Peng Q; Fang C
    Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities.
    Rinderknecht CH; Ning M; Wu C; Wilson MS; Gampe C
    Expert Opin Drug Discov; 2024 Apr; 19(4):493-506. PubMed ID: 38407117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of natural phenolic compounds for the potential treatment of lung cancer.
    Muller AG; Sarker SD; Saleem IY; Hutcheon GA
    Daru; 2019 Jun; 27(1):433-449. PubMed ID: 31115871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol pulmonary immune engineering.
    Sudduth ER; Trautmann-Rodriguez M; Gill N; Bomb K; Fromen CA
    Adv Drug Deliv Rev; 2023 Aug; 199():114831. PubMed ID: 37100206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary drug delivery strategies: A concise, systematic review.
    Patil JS; Sarasija S
    Lung India; 2012 Jan; 29(1):44-9. PubMed ID: 22345913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule.
    Rastegar-Pouyani N; Dongsar TS; Ataei M; Hassani S; Gumpricht E; Kesharwani P; Sahebkar A
    Expert Opin Drug Deliv; 2024 May; ():. PubMed ID: 38771504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalable Therapies for the Heart: Take the "Lung" Way Home?
    Hulot JS; Kupatt C
    J Am Coll Cardiol; 2024 Jan; 83(1):60-62. PubMed ID: 38171711
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Drug discovery and nano delivery of natural products.
    Ye J
    Front Pharmacol; 2024; 15():1402362. PubMed ID: 38659593
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of Factors Influencing the Effectiveness of Deformable Nanovesicles for Insulin Nebulization Inhalation.
    Yu J; Meng Y; Wen Z; Jiang Y; Guo Y; Du S; Liu Y; Xia X
    Pharmaceutics; 2024 Jun; 16(7):. PubMed ID: 39065576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases.
    Yong J; Shu H; Zhang X; Yang K; Luo G; Yu L; Li J; Huang H
    Int J Nanomedicine; 2024; 19():1723-1748. PubMed ID: 38414528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano-bio interactions.
    Zhang M; Lu H; Xie L; Liu X; Cun D; Yang M
    Adv Drug Deliv Rev; 2023 Dec; 203():115144. PubMed ID: 37995899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Updates in Inhalable Drug Delivery System against Various Pulmonary Diseases: Challenges and Future Perspectives.
    Chaudhary KR; Singh K; Singh C
    Curr Drug Deliv; 2024; 21(10):1320-1345. PubMed ID: 37870055
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.